nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—Erlotinib—pancreatic cancer	0.218	0.274	CbGbCtD
Indacaterol—UGT1A1—Irinotecan—pancreatic cancer	0.197	0.247	CbGbCtD
Indacaterol—ABCB1—Tamoxifen—pancreatic cancer	0.0508	0.0638	CbGbCtD
Indacaterol—ABCB1—Gemcitabine—pancreatic cancer	0.0438	0.055	CbGbCtD
Indacaterol—ABCB1—Erlotinib—pancreatic cancer	0.0432	0.0543	CbGbCtD
Indacaterol—ABCB1—Irinotecan—pancreatic cancer	0.039	0.049	CbGbCtD
Indacaterol—CYP3A4—Tamoxifen—pancreatic cancer	0.0305	0.0382	CbGbCtD
Indacaterol—ABCB1—Docetaxel—pancreatic cancer	0.0286	0.0359	CbGbCtD
Indacaterol—ABCB1—Sunitinib—pancreatic cancer	0.0285	0.0357	CbGbCtD
Indacaterol—CYP3A4—Erlotinib—pancreatic cancer	0.0259	0.0325	CbGbCtD
Indacaterol—CYP3A4—Irinotecan—pancreatic cancer	0.0234	0.0294	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—pancreatic cancer	0.0213	0.0268	CbGbCtD
Indacaterol—CYP3A4—Docetaxel—pancreatic cancer	0.0171	0.0215	CbGbCtD
Indacaterol—CYP3A4—Sunitinib—pancreatic cancer	0.0171	0.0214	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—pancreatic cancer	0.0128	0.016	CbGbCtD
Indacaterol—Bronchospasm—Gemcitabine—pancreatic cancer	0.000968	0.00543	CcSEcCtD
Indacaterol—Oedema peripheral—Sunitinib—pancreatic cancer	0.000967	0.00542	CcSEcCtD
Indacaterol—Connective tissue disorder—Sunitinib—pancreatic cancer	0.000964	0.00541	CcSEcCtD
Indacaterol—Muscle spasms—Tamoxifen—pancreatic cancer	0.000959	0.00538	CcSEcCtD
Indacaterol—Angina pectoris—Fluorouracil—pancreatic cancer	0.000942	0.00528	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.000939	0.00526	CcSEcCtD
Indacaterol—Anaemia—Tamoxifen—pancreatic cancer	0.000922	0.00517	CcSEcCtD
Indacaterol—Cardiac disorder—Sunitinib—pancreatic cancer	0.000911	0.00511	CcSEcCtD
Indacaterol—Pneumonia—Irinotecan—pancreatic cancer	0.000906	0.00508	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.000899	0.00504	CcSEcCtD
Indacaterol—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.000887	0.00498	CcSEcCtD
Indacaterol—Immune system disorder—Sunitinib—pancreatic cancer	0.000886	0.00497	CcSEcCtD
Indacaterol—Mediastinal disorder—Sunitinib—pancreatic cancer	0.000884	0.00496	CcSEcCtD
Indacaterol—Pneumonia—Gemcitabine—pancreatic cancer	0.000882	0.00495	CcSEcCtD
Indacaterol—Cough—Tamoxifen—pancreatic cancer	0.00087	0.00488	CcSEcCtD
Indacaterol—Pneumonia—Fluorouracil—pancreatic cancer	0.000867	0.00486	CcSEcCtD
Indacaterol—Infestation NOS—Fluorouracil—pancreatic cancer	0.000862	0.00484	CcSEcCtD
Indacaterol—Infestation—Fluorouracil—pancreatic cancer	0.000862	0.00484	CcSEcCtD
Indacaterol—Cough—Erlotinib—pancreatic cancer	0.000861	0.00483	CcSEcCtD
Indacaterol—Malnutrition—Sunitinib—pancreatic cancer	0.000854	0.00479	CcSEcCtD
Indacaterol—Atrial fibrillation—Docetaxel—pancreatic cancer	0.000852	0.00478	CcSEcCtD
Indacaterol—Chest pain—Tamoxifen—pancreatic cancer	0.000849	0.00476	CcSEcCtD
Indacaterol—Myalgia—Tamoxifen—pancreatic cancer	0.000849	0.00476	CcSEcCtD
Indacaterol—Chest pain—Erlotinib—pancreatic cancer	0.00084	0.00471	CcSEcCtD
Indacaterol—Myalgia—Erlotinib—pancreatic cancer	0.00084	0.00471	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000834	0.00468	CcSEcCtD
Indacaterol—Dry mouth—Tamoxifen—pancreatic cancer	0.00083	0.00466	CcSEcCtD
Indacaterol—Muscle spasms—Sunitinib—pancreatic cancer	0.000821	0.00461	CcSEcCtD
Indacaterol—Sinusitis—Fluorouracil—pancreatic cancer	0.000809	0.00454	CcSEcCtD
Indacaterol—Infection—Tamoxifen—pancreatic cancer	0.000809	0.00453	CcSEcCtD
Indacaterol—Infection—Erlotinib—pancreatic cancer	0.0008	0.00449	CcSEcCtD
Indacaterol—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000794	0.00445	CcSEcCtD
Indacaterol—Nervous system disorder—Erlotinib—pancreatic cancer	0.00079	0.00443	CcSEcCtD
Indacaterol—Anaemia—Sunitinib—pancreatic cancer	0.00079	0.00443	CcSEcCtD
Indacaterol—Skin disorder—Erlotinib—pancreatic cancer	0.000782	0.00439	CcSEcCtD
Indacaterol—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000776	0.00435	CcSEcCtD
Indacaterol—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000774	0.00434	CcSEcCtD
Indacaterol—Musculoskeletal pain—Epirubicin—pancreatic cancer	0.00076	0.00426	CcSEcCtD
Indacaterol—Cardiac disorder—Irinotecan—pancreatic cancer	0.00075	0.00421	CcSEcCtD
Indacaterol—Cough—Sunitinib—pancreatic cancer	0.000745	0.00418	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000742	0.00416	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000734	0.00411	CcSEcCtD
Indacaterol—Paraesthesia—Tamoxifen—pancreatic cancer	0.000731	0.0041	CcSEcCtD
Indacaterol—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000731	0.0041	CcSEcCtD
Indacaterol—Immune system disorder—Irinotecan—pancreatic cancer	0.00073	0.00409	CcSEcCtD
Indacaterol—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000728	0.00408	CcSEcCtD
Indacaterol—Chest pain—Sunitinib—pancreatic cancer	0.000727	0.00408	CcSEcCtD
Indacaterol—Myalgia—Sunitinib—pancreatic cancer	0.000727	0.00408	CcSEcCtD
Indacaterol—Dyspnoea—Tamoxifen—pancreatic cancer	0.000726	0.00407	CcSEcCtD
Indacaterol—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000722	0.00405	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000722	0.00405	CcSEcCtD
Indacaterol—Dyspnoea—Erlotinib—pancreatic cancer	0.000718	0.00403	CcSEcCtD
Indacaterol—Dry mouth—Sunitinib—pancreatic cancer	0.000711	0.00399	CcSEcCtD
Indacaterol—Immune system disorder—Gemcitabine—pancreatic cancer	0.000711	0.00399	CcSEcCtD
Indacaterol—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00071	0.00398	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—pancreatic cancer	0.000703	0.00394	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000703	0.00394	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000695	0.0039	CcSEcCtD
Indacaterol—Infection—Sunitinib—pancreatic cancer	0.000693	0.00388	CcSEcCtD
Indacaterol—Bronchospasm—Docetaxel—pancreatic cancer	0.000687	0.00385	CcSEcCtD
Indacaterol—Nervous system disorder—Sunitinib—pancreatic cancer	0.000684	0.00383	CcSEcCtD
Indacaterol—Angina pectoris—Docetaxel—pancreatic cancer	0.00068	0.00381	CcSEcCtD
Indacaterol—Skin disorder—Sunitinib—pancreatic cancer	0.000677	0.0038	CcSEcCtD
Indacaterol—Muscle spasms—Irinotecan—pancreatic cancer	0.000677	0.00379	CcSEcCtD
Indacaterol—Anaemia—Irinotecan—pancreatic cancer	0.00065	0.00365	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000635	0.00356	CcSEcCtD
Indacaterol—Anaemia—Gemcitabine—pancreatic cancer	0.000634	0.00355	CcSEcCtD
Indacaterol—Vertigo—Irinotecan—pancreatic cancer	0.000632	0.00354	CcSEcCtD
Indacaterol—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000626	0.00351	CcSEcCtD
Indacaterol—Pneumonia—Docetaxel—pancreatic cancer	0.000626	0.00351	CcSEcCtD
Indacaterol—Paraesthesia—Sunitinib—pancreatic cancer	0.000626	0.00351	CcSEcCtD
Indacaterol—Anaemia—Fluorouracil—pancreatic cancer	0.000623	0.00349	CcSEcCtD
Indacaterol—Infestation NOS—Docetaxel—pancreatic cancer	0.000622	0.00349	CcSEcCtD
Indacaterol—Infestation—Docetaxel—pancreatic cancer	0.000622	0.00349	CcSEcCtD
Indacaterol—Dyspnoea—Sunitinib—pancreatic cancer	0.000622	0.00349	CcSEcCtD
Indacaterol—Cough—Irinotecan—pancreatic cancer	0.000614	0.00344	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000602	0.00337	CcSEcCtD
Indacaterol—Hypersensitivity—Tamoxifen—pancreatic cancer	0.0006	0.00336	CcSEcCtD
Indacaterol—Cough—Gemcitabine—pancreatic cancer	0.000598	0.00335	CcSEcCtD
Indacaterol—Myalgia—Gemcitabine—pancreatic cancer	0.000584	0.00327	CcSEcCtD
Indacaterol—Chest pain—Gemcitabine—pancreatic cancer	0.000584	0.00327	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.00058	0.00325	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00058	0.00325	CcSEcCtD
Indacaterol—Pruritus—Tamoxifen—pancreatic cancer	0.000576	0.00323	CcSEcCtD
Indacaterol—Chest pain—Fluorouracil—pancreatic cancer	0.000574	0.00322	CcSEcCtD
Indacaterol—Myalgia—Fluorouracil—pancreatic cancer	0.000574	0.00322	CcSEcCtD
Indacaterol—Infection—Irinotecan—pancreatic cancer	0.000571	0.0032	CcSEcCtD
Indacaterol—Pruritus—Erlotinib—pancreatic cancer	0.00057	0.00319	CcSEcCtD
Indacaterol—Nervous system disorder—Irinotecan—pancreatic cancer	0.000563	0.00316	CcSEcCtD
Indacaterol—Infection—Gemcitabine—pancreatic cancer	0.000556	0.00312	CcSEcCtD
Indacaterol—Oedema peripheral—Docetaxel—pancreatic cancer	0.00055	0.00309	CcSEcCtD
Indacaterol—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000549	0.00308	CcSEcCtD
Indacaterol—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000549	0.00308	CcSEcCtD
Indacaterol—Infection—Fluorouracil—pancreatic cancer	0.000546	0.00306	CcSEcCtD
Indacaterol—Skin disorder—Gemcitabine—pancreatic cancer	0.000543	0.00305	CcSEcCtD
Indacaterol—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000539	0.00302	CcSEcCtD
Indacaterol—Dizziness—Tamoxifen—pancreatic cancer	0.000538	0.00302	CcSEcCtD
Indacaterol—Tachycardia—Fluorouracil—pancreatic cancer	0.000537	0.00301	CcSEcCtD
Indacaterol—Dizziness—Erlotinib—pancreatic cancer	0.000533	0.00299	CcSEcCtD
Indacaterol—Cardiac disorder—Docetaxel—pancreatic cancer	0.000519	0.00291	CcSEcCtD
Indacaterol—Paraesthesia—Irinotecan—pancreatic cancer	0.000516	0.00289	CcSEcCtD
Indacaterol—Hypersensitivity—Sunitinib—pancreatic cancer	0.000514	0.00288	CcSEcCtD
Indacaterol—Rash—Tamoxifen—pancreatic cancer	0.000513	0.00288	CcSEcCtD
Indacaterol—Dermatitis—Tamoxifen—pancreatic cancer	0.000513	0.00288	CcSEcCtD
Indacaterol—Dyspnoea—Irinotecan—pancreatic cancer	0.000512	0.00287	CcSEcCtD
Indacaterol—Headache—Tamoxifen—pancreatic cancer	0.00051	0.00286	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00051	0.00286	CcSEcCtD
Indacaterol—Rash—Erlotinib—pancreatic cancer	0.000508	0.00285	CcSEcCtD
Indacaterol—Dermatitis—Erlotinib—pancreatic cancer	0.000507	0.00284	CcSEcCtD
Indacaterol—Immune system disorder—Docetaxel—pancreatic cancer	0.000505	0.00283	CcSEcCtD
Indacaterol—Headache—Erlotinib—pancreatic cancer	0.000505	0.00283	CcSEcCtD
Indacaterol—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000504	0.00282	CcSEcCtD
Indacaterol—Paraesthesia—Gemcitabine—pancreatic cancer	0.000502	0.00282	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000501	0.00281	CcSEcCtD
Indacaterol—Dyspnoea—Gemcitabine—pancreatic cancer	0.000499	0.0028	CcSEcCtD
Indacaterol—Hypokalaemia—Epirubicin—pancreatic cancer	0.000496	0.00278	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000496	0.00278	CcSEcCtD
Indacaterol—Paraesthesia—Fluorouracil—pancreatic cancer	0.000494	0.00277	CcSEcCtD
Indacaterol—Pruritus—Sunitinib—pancreatic cancer	0.000493	0.00277	CcSEcCtD
Indacaterol—Dyspnoea—Fluorouracil—pancreatic cancer	0.00049	0.00275	CcSEcCtD
Indacaterol—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000487	0.00273	CcSEcCtD
Indacaterol—Malnutrition—Docetaxel—pancreatic cancer	0.000486	0.00273	CcSEcCtD
Indacaterol—Nausea—Tamoxifen—pancreatic cancer	0.000483	0.00271	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000483	0.00271	CcSEcCtD
Indacaterol—Nausea—Erlotinib—pancreatic cancer	0.000478	0.00268	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000475	0.00266	CcSEcCtD
Indacaterol—Asthma—Epirubicin—pancreatic cancer	0.000471	0.00264	CcSEcCtD
Indacaterol—Muscle spasms—Docetaxel—pancreatic cancer	0.000468	0.00262	CcSEcCtD
Indacaterol—Dizziness—Sunitinib—pancreatic cancer	0.000461	0.00259	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000459	0.00257	CcSEcCtD
Indacaterol—Angina pectoris—Epirubicin—pancreatic cancer	0.000459	0.00257	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000451	0.00253	CcSEcCtD
Indacaterol—Anaemia—Docetaxel—pancreatic cancer	0.00045	0.00252	CcSEcCtD
Indacaterol—Rash—Sunitinib—pancreatic cancer	0.00044	0.00246	CcSEcCtD
Indacaterol—Dermatitis—Sunitinib—pancreatic cancer	0.000439	0.00246	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000438	0.00245	CcSEcCtD
Indacaterol—Headache—Sunitinib—pancreatic cancer	0.000437	0.00245	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—pancreatic cancer	0.000436	0.00244	CcSEcCtD
Indacaterol—Palpitations—Docetaxel—pancreatic cancer	0.00043	0.00241	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000425	0.00238	CcSEcCtD
Indacaterol—Cough—Docetaxel—pancreatic cancer	0.000424	0.00238	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—pancreatic cancer	0.000424	0.00238	CcSEcCtD
Indacaterol—Hypersensitivity—Irinotecan—pancreatic cancer	0.000423	0.00237	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—pancreatic cancer	0.000422	0.00237	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—pancreatic cancer	0.00042	0.00235	CcSEcCtD
Indacaterol—Infestation—Epirubicin—pancreatic cancer	0.00042	0.00235	CcSEcCtD
Indacaterol—Chest pain—Docetaxel—pancreatic cancer	0.000414	0.00232	CcSEcCtD
Indacaterol—Myalgia—Docetaxel—pancreatic cancer	0.000414	0.00232	CcSEcCtD
Indacaterol—Nausea—Sunitinib—pancreatic cancer	0.000414	0.00232	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000411	0.00231	CcSEcCtD
Indacaterol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000405	0.00227	CcSEcCtD
Indacaterol—Dry mouth—Docetaxel—pancreatic cancer	0.000405	0.00227	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000405	0.00227	CcSEcCtD
Indacaterol—Pruritus—Gemcitabine—pancreatic cancer	0.000396	0.00222	CcSEcCtD
Indacaterol—Infection—Docetaxel—pancreatic cancer	0.000394	0.00221	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—pancreatic cancer	0.000394	0.00221	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000393	0.0022	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—pancreatic cancer	0.000391	0.00219	CcSEcCtD
Indacaterol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000389	0.00218	CcSEcCtD
Indacaterol—Pruritus—Fluorouracil—pancreatic cancer	0.000389	0.00218	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—pancreatic cancer	0.000388	0.00218	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—pancreatic cancer	0.000388	0.00218	CcSEcCtD
Indacaterol—Tachycardia—Docetaxel—pancreatic cancer	0.000387	0.00217	CcSEcCtD
Indacaterol—Skin disorder—Docetaxel—pancreatic cancer	0.000386	0.00216	CcSEcCtD
Indacaterol—Dizziness—Irinotecan—pancreatic cancer	0.00038	0.00213	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—pancreatic cancer	0.000371	0.00208	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00037	0.00208	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—pancreatic cancer	0.000364	0.00204	CcSEcCtD
Indacaterol—Dizziness—Fluorouracil—pancreatic cancer	0.000364	0.00204	CcSEcCtD
Indacaterol—Rash—Irinotecan—pancreatic cancer	0.000362	0.00203	CcSEcCtD
Indacaterol—Dermatitis—Irinotecan—pancreatic cancer	0.000362	0.00203	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000362	0.00203	CcSEcCtD
Indacaterol—Headache—Irinotecan—pancreatic cancer	0.00036	0.00202	CcSEcCtD
Indacaterol—Paraesthesia—Docetaxel—pancreatic cancer	0.000356	0.002	CcSEcCtD
Indacaterol—Dyspnoea—Docetaxel—pancreatic cancer	0.000354	0.00198	CcSEcCtD
Indacaterol—Rash—Gemcitabine—pancreatic cancer	0.000353	0.00198	CcSEcCtD
Indacaterol—Dermatitis—Gemcitabine—pancreatic cancer	0.000352	0.00198	CcSEcCtD
Indacaterol—Headache—Gemcitabine—pancreatic cancer	0.00035	0.00197	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—pancreatic cancer	0.00035	0.00196	CcSEcCtD
Indacaterol—Rash—Fluorouracil—pancreatic cancer	0.000347	0.00194	CcSEcCtD
Indacaterol—Dermatitis—Fluorouracil—pancreatic cancer	0.000346	0.00194	CcSEcCtD
Indacaterol—Headache—Fluorouracil—pancreatic cancer	0.000345	0.00193	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000344	0.00193	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000343	0.00192	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000343	0.00192	CcSEcCtD
Indacaterol—Nausea—Irinotecan—pancreatic cancer	0.000341	0.00191	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—pancreatic cancer	0.00034	0.00191	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00034	0.0019	CcSEcCtD
Indacaterol—Nausea—Gemcitabine—pancreatic cancer	0.000332	0.00186	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—pancreatic cancer	0.000328	0.00184	CcSEcCtD
Indacaterol—Nausea—Fluorouracil—pancreatic cancer	0.000327	0.00183	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000324	0.00181	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—pancreatic cancer	0.000315	0.00177	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—pancreatic cancer	0.000315	0.00177	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000314	0.00176	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—pancreatic cancer	0.000304	0.0017	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—pancreatic cancer	0.000303	0.0017	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—pancreatic cancer	0.000295	0.00165	CcSEcCtD
Indacaterol—Hypersensitivity—Docetaxel—pancreatic cancer	0.000292	0.00164	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—pancreatic cancer	0.000292	0.00164	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—pancreatic cancer	0.00029	0.00163	CcSEcCtD
Indacaterol—Cough—Epirubicin—pancreatic cancer	0.000286	0.00161	CcSEcCtD
Indacaterol—Pruritus—Docetaxel—pancreatic cancer	0.000281	0.00157	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—pancreatic cancer	0.000281	0.00157	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—pancreatic cancer	0.000279	0.00157	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—pancreatic cancer	0.000279	0.00157	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000277	0.00156	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—pancreatic cancer	0.000273	0.00153	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—pancreatic cancer	0.000273	0.00153	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—pancreatic cancer	0.000268	0.0015	CcSEcCtD
Indacaterol—Infection—Epirubicin—pancreatic cancer	0.000266	0.00149	CcSEcCtD
Indacaterol—Cough—Doxorubicin—pancreatic cancer	0.000265	0.00149	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—pancreatic cancer	0.000263	0.00147	CcSEcCtD
Indacaterol—Dizziness—Docetaxel—pancreatic cancer	0.000263	0.00147	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—pancreatic cancer	0.000261	0.00147	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—pancreatic cancer	0.00026	0.00146	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—pancreatic cancer	0.000258	0.00145	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—pancreatic cancer	0.000258	0.00145	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000257	0.00144	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—pancreatic cancer	0.000253	0.00142	CcSEcCtD
Indacaterol—Rash—Docetaxel—pancreatic cancer	0.00025	0.0014	CcSEcCtD
Indacaterol—Dermatitis—Docetaxel—pancreatic cancer	0.00025	0.0014	CcSEcCtD
Indacaterol—Headache—Docetaxel—pancreatic cancer	0.000249	0.00139	CcSEcCtD
Indacaterol—Infection—Doxorubicin—pancreatic cancer	0.000246	0.00138	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000244	0.00137	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000243	0.00136	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—pancreatic cancer	0.000242	0.00136	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—pancreatic cancer	0.000241	0.00135	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—pancreatic cancer	0.00024	0.00135	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—pancreatic cancer	0.000239	0.00134	CcSEcCtD
Indacaterol—Nausea—Docetaxel—pancreatic cancer	0.000236	0.00132	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000231	0.0013	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000226	0.00127	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000222	0.00125	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000221	0.00124	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000214	0.0012	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000197	0.00111	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—pancreatic cancer	0.000189	0.00106	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000183	0.00102	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—pancreatic cancer	0.000177	0.000993	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—pancreatic cancer	0.000175	0.000983	CcSEcCtD
Indacaterol—Rash—Epirubicin—pancreatic cancer	0.000169	0.000947	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—pancreatic cancer	0.000169	0.000946	CcSEcCtD
Indacaterol—Headache—Epirubicin—pancreatic cancer	0.000168	0.000941	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—pancreatic cancer	0.000164	0.000919	CcSEcCtD
Indacaterol—Nausea—Epirubicin—pancreatic cancer	0.000159	0.000892	CcSEcCtD
Indacaterol—Rash—Doxorubicin—pancreatic cancer	0.000156	0.000876	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—pancreatic cancer	0.000156	0.000875	CcSEcCtD
Indacaterol—Headache—Doxorubicin—pancreatic cancer	0.000155	0.00087	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—pancreatic cancer	0.000147	0.000825	CcSEcCtD
Indacaterol—ADRB1—Signaling by GPCR—PTCH1—pancreatic cancer	3.22e-05	0.00129	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.19e-05	0.00128	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.17e-05	0.00127	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	3.17e-05	0.00127	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	3.17e-05	0.00127	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	3.15e-05	0.00126	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	3.15e-05	0.00126	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PPY—pancreatic cancer	3.11e-05	0.00125	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	3.1e-05	0.00124	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	3.05e-05	0.00122	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PPY—pancreatic cancer	3.04e-05	0.00122	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.04e-05	0.00122	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GLP1R—pancreatic cancer	3.03e-05	0.00121	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	2.99e-05	0.0012	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	2.99e-05	0.0012	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—DPYD—pancreatic cancer	2.98e-05	0.00119	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	2.95e-05	0.00118	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—SST—pancreatic cancer	2.94e-05	0.00118	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	2.93e-05	0.00118	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	2.92e-05	0.00117	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	2.89e-05	0.00116	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	2.88e-05	0.00116	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	2.88e-05	0.00115	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	2.87e-05	0.00115	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—SLC2A2—pancreatic cancer	2.83e-05	0.00113	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	2.82e-05	0.00113	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	2.77e-05	0.00111	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	2.77e-05	0.00111	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.77e-05	0.00111	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	2.75e-05	0.0011	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.74e-05	0.0011	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	2.72e-05	0.00109	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	2.71e-05	0.00109	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	2.71e-05	0.00109	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	2.7e-05	0.00108	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	2.7e-05	0.00108	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	2.69e-05	0.00108	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	2.66e-05	0.00106	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	2.64e-05	0.00106	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	2.64e-05	0.00106	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	2.62e-05	0.00105	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	2.6e-05	0.00104	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	2.57e-05	0.00103	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	2.54e-05	0.00102	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	2.54e-05	0.00102	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	2.5e-05	0.001	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	2.48e-05	0.000994	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	2.45e-05	0.000981	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	2.4e-05	0.000963	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	2.4e-05	0.000963	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	2.35e-05	0.000942	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	2.35e-05	0.000942	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.33e-05	0.000935	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	2.29e-05	0.000919	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.27e-05	0.000911	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	2.24e-05	0.000899	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	2.23e-05	0.000895	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	2.23e-05	0.000895	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	2.23e-05	0.000895	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	2.2e-05	0.000881	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CD44—pancreatic cancer	2.19e-05	0.000877	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	2.19e-05	0.000876	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	2.19e-05	0.000876	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	2.18e-05	0.000875	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.17e-05	0.000868	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	2.15e-05	0.000862	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	2.13e-05	0.000854	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.11e-05	0.000845	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	2.1e-05	0.000842	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GCG—pancreatic cancer	2.1e-05	0.000841	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.09e-05	0.000837	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	2.09e-05	0.000836	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	2.06e-05	0.000824	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.04e-05	0.000816	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	2e-05	0.000803	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	1.99e-05	0.000798	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	1.98e-05	0.000793	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—STK11—pancreatic cancer	1.97e-05	0.000791	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ARG2—pancreatic cancer	1.97e-05	0.00079	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	1.96e-05	0.000786	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	1.95e-05	0.000781	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	1.94e-05	0.000776	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	1.9e-05	0.000761	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	1.9e-05	0.000761	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.89e-05	0.000756	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	1.86e-05	0.000745	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	1.86e-05	0.000745	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.84e-05	0.000737	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SST—pancreatic cancer	1.74e-05	0.000696	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—TYMP—pancreatic cancer	1.72e-05	0.000691	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.71e-05	0.000687	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	1.7e-05	0.000681	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SST—pancreatic cancer	1.7e-05	0.000681	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—TYMS—pancreatic cancer	1.7e-05	0.00068	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	1.69e-05	0.000679	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.69e-05	0.000678	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.69e-05	0.000676	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.68e-05	0.000672	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	1.66e-05	0.000667	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	1.66e-05	0.000664	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.65e-05	0.000663	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	1.6e-05	0.000643	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.58e-05	0.000631	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	1.57e-05	0.000629	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.56e-05	0.000626	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.56e-05	0.000624	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	1.55e-05	0.000621	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.52e-05	0.00061	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	1.52e-05	0.000607	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.51e-05	0.000604	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	1.48e-05	0.000592	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.47e-05	0.000591	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	1.46e-05	0.000584	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	1.45e-05	0.000579	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.44e-05	0.000575	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	1.42e-05	0.000571	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.4e-05	0.000561	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.39e-05	0.000557	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.39e-05	0.000557	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—APOE—pancreatic cancer	1.38e-05	0.000553	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.37e-05	0.000548	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—DPYD—pancreatic cancer	1.37e-05	0.000548	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.34e-05	0.000536	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.31e-05	0.000526	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.3e-05	0.00052	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.28e-05	0.000515	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	1.28e-05	0.000511	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.26e-05	0.000506	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	1.25e-05	0.0005	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CG—pancreatic cancer	1.25e-05	0.000499	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	1.25e-05	0.000499	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.23e-05	0.000495	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	1.22e-05	0.000488	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.22e-05	0.000487	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PPARG—pancreatic cancer	1.2e-05	0.000482	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.19e-05	0.000478	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.17e-05	0.00047	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.17e-05	0.000468	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	1.15e-05	0.000459	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	1.12e-05	0.000449	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	1.1e-05	0.000439	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	1.09e-05	0.000437	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	1.07e-05	0.000428	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.06e-05	0.000426	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	1.04e-05	0.000418	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	1.04e-05	0.000417	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	1.02e-05	0.000409	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	1.02e-05	0.000408	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	1.02e-05	0.000408	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CD44—pancreatic cancer	1e-05	0.000402	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	9.98e-06	0.0004	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	9.97e-06	0.000399	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	9.76e-06	0.000391	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GCG—pancreatic cancer	9.63e-06	0.000386	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	9.55e-06	0.000383	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	9.49e-06	0.00038	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTGS2—pancreatic cancer	9.46e-06	0.000379	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	9.4e-06	0.000377	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	9.29e-06	0.000372	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	9.2e-06	0.000369	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	9.2e-06	0.000368	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	9.2e-06	0.000368	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	9.09e-06	0.000364	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—STK11—pancreatic cancer	9.05e-06	0.000363	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	9e-06	0.00036	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	9e-06	0.00036	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	8.89e-06	0.000356	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GLP1R—pancreatic cancer	8.56e-06	0.000343	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—DPYD—pancreatic cancer	8.42e-06	0.000337	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	8.38e-06	0.000336	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTEN—pancreatic cancer	8.25e-06	0.000331	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	8.2e-06	0.000328	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	8.08e-06	0.000324	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.01e-06	0.000321	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	7.99e-06	0.00032	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	7.91e-06	0.000317	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	7.91e-06	0.000317	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.83e-06	0.000314	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—TYMS—pancreatic cancer	7.79e-06	0.000312	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	7.74e-06	0.00031	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	7.27e-06	0.000291	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	7.11e-06	0.000285	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	7.05e-06	0.000282	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	6.89e-06	0.000276	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	6.77e-06	0.000271	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	6.73e-06	0.00027	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	6.62e-06	0.000265	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	6.58e-06	0.000264	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	6.54e-06	0.000262	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	6.48e-06	0.00026	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	6.4e-06	0.000256	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	6.34e-06	0.000254	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APOE—pancreatic cancer	6.33e-06	0.000254	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	6.31e-06	0.000253	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	6.25e-06	0.00025	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CD44—pancreatic cancer	6.19e-06	0.000248	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	6.17e-06	0.000247	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	6.12e-06	0.000245	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	6.11e-06	0.000245	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	6.09e-06	0.000244	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	5.99e-06	0.00024	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	5.96e-06	0.000239	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	5.94e-06	0.000238	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GCG—pancreatic cancer	5.93e-06	0.000238	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	5.82e-06	0.000233	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	5.81e-06	0.000233	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CG—pancreatic cancer	5.72e-06	0.000229	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	5.65e-06	0.000226	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—STK11—pancreatic cancer	5.58e-06	0.000224	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	5.52e-06	0.000221	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPARG—pancreatic cancer	5.52e-06	0.000221	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	5.5e-06	0.00022	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	5.45e-06	0.000218	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	5.43e-06	0.000218	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	5.38e-06	0.000216	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	5.33e-06	0.000213	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	5.31e-06	0.000213	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	5.06e-06	0.000203	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	5.05e-06	0.000202	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.03e-06	0.000201	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	4.95e-06	0.000198	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	4.95e-06	0.000198	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	4.94e-06	0.000198	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	4.84e-06	0.000194	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TYMS—pancreatic cancer	4.8e-06	0.000192	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—AKT1—pancreatic cancer	4.76e-06	0.000191	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	4.68e-06	0.000187	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	4.57e-06	0.000183	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.38e-06	0.000176	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.34e-06	0.000174	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	4.3e-06	0.000172	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	4.2e-06	0.000168	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	4.16e-06	0.000166	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	4.06e-06	0.000163	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	3.97e-06	0.000159	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APOE—pancreatic cancer	3.9e-06	0.000156	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	3.89e-06	0.000156	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTEN—pancreatic cancer	3.79e-06	0.000152	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.52e-06	0.000141	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	3.51e-06	0.000141	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	3.43e-06	0.000138	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.4e-06	0.000136	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.1e-06	0.000124	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.7e-06	0.000108	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.67e-06	0.000107	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.67e-06	0.000107	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.33e-06	9.34e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AKT1—pancreatic cancer	2.18e-06	8.74e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.65e-06	6.59e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.34e-06	5.39e-05	CbGpPWpGaD
